NGHIÊN CỨU ĐẶC ĐIỂM NIỆU DÒNG ĐỒ VÀ ĐÁNH GIÁ KẾT QUẢ ĐIỀU TRỊ SỚM BỆNH NHÂN TĂNG SINH LÀNH TÍNH TUYẾN TIỀN LIỆT BẰNG THUỐC TAMSULOSIN TẠI BỆNH VIỆN TRƯỜNG ĐẠI HỌC Y DƯỢC CẦN THƠ

Abstract

Background: Benign prostatic hyperplasia is a common disease in older men and can greatly affect the patient's quality of life, so early diagnosis and treatment is essential, we research of characteristics of uroflowmetry and evaluate of early results of treatment for benign prostatic hyperplasia with drugs tamsulosin at Can Tho university of medicine and pharmacy hospital. Objectives: To research of characteristics of uroflowmetry and evaluate of early results of treatment for benign prostatic hyperplasia with drugs tamsulosin at Can Tho university of medicine and pharmacy hospital. Materials and methods: A sectional descriptive study was conducted on 67 patients with benign prostatic hyperplasia were treated with drugs tamsulosin from 01/01/2023 to 31/08/2023 at Can Tho University of Medicine and Pharmacy Hospital. Results: The average age of patients was 77.43 ± 10.31, the most common reason for admission was dysuria 37.31%, before treatment, average point of IPSS was 19.63 ± 6.895, average point of QoL was 4.73 ± 0.975, average weight of Prostate was 47.95 ± 19.281gram, average of Qmax was 7.8 ± 1.26 ml/s, average of PSA was 10.441 ± 6.9996ng/ml. After 4 weeks of treatment with drugs Tamsulosin average point of IPSS was 10.95±5.696, difference of 8,68 points, average point of QoL was 2.83±1.046, difference of 1.90 points, average of Qmax was 17.52 ± 1.79 ml/s, complications: 4.48% dizzy, 2.99% headache, 4.48% postural hypotension, 1.49% uncomfortable. Conclusion: Early treatment of benign prostatic hypertrophy with Tamsulosin achieves high treatment results, clinical symptoms and quality of life are improved.